Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up
Open Access
- 1 February 1998
- Vol. 51 (2) , 237-240
- https://doi.org/10.1016/s0090-4295(97)00614-6
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Efficacy of Terazosin, Finasteride, or Both in Benign Prostatic HyperplasiaNew England Journal of Medicine, 1996
- Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.Endocrinology, 1995
- Maintenance of Clinical Efficacy With Finasteride Therapy for 24 Months in Patients With Benign Prostatic HyperplasiaArchives of internal medicine (1960), 1994
- Treatment of Prostatic Bleeding: Suppression of Angiogenesis by Androgen DeprivationJournal of Urology, 1993
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- The Clinical Effects of a 5α-Reductase Inhibitor, Finasteride, on Benign Prostatic HyperplasiaJournal of Urology, 1992
- Induction of the TRPM-2 gene in cells undergoing programmed death.Molecular and Cellular Biology, 1989
- Epsilon Aminocaproic Acid and the Control of Post-Prostatectomy Bleeding: A Prospective Double-Blind StudyJournal of Urology, 1984
- Epsilon-Aminocaproic Acid (EACA)Seminars in Thrombosis and Hemostasis, 1978